# Biogen announces $2B manufacturing investment in North Carolina's Research Triangle Park

Biogen intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park, expanding ASO capabilities and adding fill-finish capacity.

- Type: Investment
- Announced: 2025-07-21
- Where: Research Triangle Park, North Carolina, United States
- Value: $2.00B
- Status: announced
- Products: antisense oligonucleotides, biopharmaceuticals
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Biogen](https://endata.com/companies/86147.md)

## Sources

- [investors.biogen.com](https://investors.biogen.com/news-releases/news-release-details/biogen-announces-2-billion-manufacturing-investment-north), 2025-07-21: "With this investment, we will modernize and expand our manufacturing capability to enable our pipeline and provide resilient patient supply, while continuing to support the skilled and dedicated community of life sciences talent in North Carolina."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.